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Objectives. This study sought to assess the differences in
coronary flow reserve in patients with and without diabetic
retinopathy.
Background. Microvascular abnormalities throughout the body
and impairment of coronary flow reserve have been described in
patients with diabetes mellitus. However, the relation between
diabetic retinopathy and coronary microvascular disease has not
been investigated.
Methods. The study included 29 patients with diabetes mellitus
(18 with and 11 without diabetic retinopathy) and 15 control
patients with chest pain and normal coronary arteries. Diabetic
retinopathy was nonproliferative in all 18 patients with this
disorder (8 had background, 10 preproliferative retinopathy). Five
minutes after injection of 3 mg of isosorbide dinitrate, phasic flow
velocities were recorded in the proximal segment of the angio-
graphically normal left anterior descending coronary artery at
rest and during hyperemia (0.14 mg/kg body weight per min of
adenosine infused intravenously) using a 0.014-in. 15-MHz Dopp-
ler guide wire. Coronary blood flow was calculated, and coronary
flow reserve was obtained from the hyperemic/baseline flow ratio.
Results. Coronary blood flow was significantly lower during
hyperemia ([mean 6 SD] 107 6 23 and 116 6 18 vs. 136 6
17 ml/min, respectively) and higher at baseline (58 6 16 and 45 6
12 vs. 37 6 10 ml/min, respectively) in diabetic patients with and
without retinopathy than in control subjects (p < 0.05 for both
diabetic groups). As a result, coronary flow reserve in both groups
of diabetic patients was significantly lower than in control pa-
tients (1.9 6 0.4 and 2.8 6 0.3 vs. 3.3 6 0.4, respectively, p < 0.01
for both diabetic groups), and its reduction was greater in patients
with than without retinopathy (p < 0.01). Furthermore, in pa-
tients with diabetic retinopathy, maximal hyperemic coronary flow
(102 6 11 vs. 114 6 16 ml/min, p < 0.05) and flow reserve (1.6 6
0.2 vs. 2.3 6 0.2, p < 0.01) were significantly lower in those with
preproliferative than background retinopathy.
Conclusions. Coronary flow reserve is significantly restricted in
patients with diabetes mellitus, and its reduction is more marked
in those with diabetic retinopathy, especially in advanced retinop-
athy. Thus, diabetic retinopathy should identify marked restric-
tion of coronary flow reserve in patients with diabetes mellitus.
(J Am Coll Cardiol 1997;30:935–41)
©1997 by the American College of Cardiology
Wall thickening and lumen narrowing of the intramural coro-
nary microvasculature have been described in patients with
diabetes mellitus (1). It has been reported (2,3) that coronary
flow reserve is limited in patients with microvascular dysfunc-
tion. Thus, restricted coronary flow reserve can be expected in
patients with diabetes mellitus and has been recently demon-
strated in diabetic patients with angiographically normal cor-
onary arteries (4,5). Retinopathy is a well known complication
of microangiopathy in diabetes mellitus, and its presence
would be a useful clinical index of microvascular damage (6).
However, the relation between diabetic retinopathy and coro-
nary microvascular disease has not been investigated.
A recently developed Doppler guide wire has been used to
measure phasic spectral flow velocity in human coronary
arteries with ease and safety (7–10), and coronary flow reserve
has also been measured, from the distal portion to the stenosis,
across stenotic coronary artery lesions (7,10). Using this
method, coronary flow and coronary flow reserve could be
easily assessed, with no disturbance in flow in patients with no
organic stenosis (8). This study thus sought to assess differ-
ences in coronary flow reserve between patients with and
without diabetic retinopathy.
Methods
Study patients. The study included 29 patients (22 men,
and 7 women; mean [6SD] age 60 6 7 years, range 44 to 69)
with non–insulin-dependent diabetes mellitus with positive
exercise treadmill test results and an angiographically normal
left anterior descending coronary artery. Of these 29 patients,
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18 had diabetic retinopathy. Fifteen patients with no diabetes
mellitus and angiographically normal coronary arteries who
were referred for cardiac catheterization for evaluation of
chest pain served as control patients (mean age 61 6 8 years,
range 45 to 70). Patients with left ventricular hypertrophy, left
ventricular dysfunction or a history of electrocardiographic
(ECG) findings of old myocardial infarction, valvular heart
disease, hypertension (.160/95 mm Hg) and miscellaneous
ECG abnormalities were excluded from the study. Diabetic
patients with stenotic lesions .25% in the left circumflex or
right coronary artery were also excluded. After written in-
formed consent was obtained, cardiac catheterization, coro-
nary angiography and the subsequent coronary flow velocity
recordings were carried out as part of diagnostic procedure
during the same catheterization procedure.
Fluorescein angiography. Diabetic retinopathy was diag-
nosed by ophthalmoscopy and fluorescein angiography within
1 week before or after cardiac catheterization by two ophthal-
mologists at our hospital who had no knowledge of the results
of coronary angiography and the coronary flow data.
Echocardiographic examination. Two-dimensional and M-
mode echocardiograms were recorded within 1 week before
cardiac catheterization. Left ventricular wall thickness and
dimensions were measured from the M-mode echocardio-
grams, and left ventricular mass was calculated from two-
dimensional echocardiograms by use of a previously described
algorithm according to the recommendations of the American
Society of Echocardiography (11–13).
Cardiac catheterization and angiography. All medications,
except sublingual nitroglycerin for emergency purposes, were
terminated at least 24 h before cardiac catheterization. After
sedation with 5 mg of oral diazepam, patients were taken to the
cardiac catheterization laboratory. Any drugs likely to affect
coronary hemodynamic variables (including nitroglycerin)
were not used during the catheterization procedure before
selective coronary angiography.
Cardiac catheterization was carried out by the femoral
approach after local anesthesia with 0.5% lidocaine. The left
ventricle was approached in a retrograde manner. Left and
right heart pressure data were recorded using a fluid-filled
catheter–transducer system before coronary angiography. Car-
diac output was measured by the thermodilution method.
Selective coronary angiography was performed by the Judkins
technique using a 5F coronary angiography catheter (Selecon,
Clinical Supply, Inc.) after intravenous injection of 4,000 U of
heparin and 3 mg of isosorbide dinitrate. Coronary stenosis
was diagnosed by visual inspection at the time of coronary
angiography before flow velocity recording and was confirmed
quantitatively with the use of off-line videodensitometric anal-
ysis performed with a commercially available system (CMS,
Medical Imaging Systems, Inc.), as previously reported (14,15).
To assess the diameters of the left anterior descending
coronary artery at the position corresponding to the tip of the
Doppler guide wire where flow velocity was recorded, coronary
angiography was analyzed quantitatively using the same video-
densitometric method as that described above.
Coronary flow velocity recordings. Phasic coronary flow
velocity patterns were recorded at rest and during hyperemia
induced by 140 mg/kg body weight per min of adenosine
(Adenocard, Fujisawa USA, Inc.) infused intravenously in the
proximal left anterior descending coronary artery using a
0.014-in. 15-MHz Doppler guide wire (FloWire, Cardiomet-
rics, Inc.) and a velocimeter (FloMap, Cardiometrics, Inc.)
(7–10) after selective coronary angiography after intravenous
isosorbide dinitrate injection. The pulse repetition frequency
of the Doppler flowmeter was variable, from 12 to 96 kHz
within the velocity range selected.
The Doppler guide wire was advanced into the proximal left
anterior descending coronary artery through a coronary an-
giography catheter using a technique similar to guide wire
manipulation during percutaneous transluminal coronary an-
gioplasty. An optimal Doppler signal was obtained by moving
the guide wire slightly within the vessel lumen and adjusting
the range gate control. The final position of the Doppler guide
wire was confirmed by contrast injection. During the Doppler
study, a 12-lead surface ECG and pressure waveform at the tip
of the guiding catheter were continuously monitored.
Frequency analysis of the Doppler signals was carried out in
real time by fast Fourier transform using a velocimeter (Flo-
Map, Cardiometrics, Inc.) (8). Five minutes after injection of
contrast medium and isosorbide dinitrate, Doppler signals
were recorded at rest and during hyperemia on videotape and
by a videoprinter along with an ECG and aortic pressure
tracing. Systolic and diastolic peak velocities and the time
average of the instantaneous spectral peak velocity (time-
averaged peak velocity) were measured from the phasic
coronary flow velocity recordings. Using previously reported
formula (8), coronary flow volume was calculated as Q 5
p(D/2)2 3 (0.5 3 APV), where Q 5 coronary flow volume;
D 5 coronary diameter at the position of the sample volume
obtained by quantitative coronary angiography; and APV 5
time-averaged peak velocity. Coronary flow reserve was ob-
tained from the ratio of maximal hyperemic to baseline rest
flow volume.
Statistical analysis. Results are expressed as mean value 6
SD. One-way analysis of variance (ANOVA) was used to
compare the three groups (diabetic patients with and without
retinopathy and control patients) for clinical characteristics,
catheterization data and flow velocity data. A Fisher protected
least significant difference test was carried out if the ANOVA
showed significant differences. An unpaired two-tailed t test
was performed to compare patients with and without retinop-
athy and patients with background and preproliferative reti-
nopathy. A probability value ,0.05 was considered significant.
Abbreviations and Acronyms
ANOVA 5 analysis of variance
ECG 5 electrocardiogram, electrocardiographic
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Results
Diabetic retinopathy. Diabetic retinopathy was diagnosed
in 18 of 29 patients with diabetes mellitus and was nonprolif-
erative in all 18 (8 had background retinopathy [early diabetic
retinopathy], 10 had preproliferative retinopathy [slightly ad-
vanced diabetic retinopathy]).
Clinical characteristics and echocardiographic and cardiac
catheterization data (Tables 1 and 2). Compared with control
patients, there were no significant differences in patients with
and without diabetic retinopathy with regard to patient age,
left ventricular dimension, interventricular and posterior left
ventricular wall thickness, left ventricular mass index, left ventric-
ular end-diastolic and end-systolic volume index, left ventricular
ejection fraction, cardiac index, mean aortic pressure, left ventric-
ular end-diastolic pressure and pulmonary capillary wedge pres-
sure. As also indicated in Table 1, fasting blood glucose and
glycohemoglobin A1c levels were significantly higher in both
groups of diabetic patients than those in control patients, and
glycohemoglobin A1c levels were higher in patients with than
without diabetic retinopathy (p , 0.01). Although hypercholes-
terolemia was found in four patients with and three without
diabetic retinopathy and in four control patients, there were no
significant differences in blood cholesterol and triglyceride levels
among three groups. Although the diameter of the proximal left
anterior descending coronary artery, where the tip of the Doppler
guide wire was placed and flow velocity was recorded, was
significantly smaller in patients with and without diabetic retinop-
athy than in control patients, there were no significant differences
in left anterior descending coronary artery diameter between
patients with and without retinopathy. In diabetic patients, coro-
nary stenosis ,25% was demonstrated in the right coronary
artery in two patients and in the left circumflex coronary artery in
three, but no stenotic coronary lesions were found in the remain-
ing 24.
Coronary flow and flow velocity data (Table 3, Fig. 1).
Baseline coronary flow and flow velocity were significantly
greater in diabetic patients with and without retinopathy than
in control patients and were more pronounced in patients with
than without diabetic retinopathy (p , 0.05 and p , 0.01,
respectively). Furthermore, in patients with diabetic retinopa-
Table 2. Echocardiographic and Cardiac Catheterization Data
Diabetic Patients (mean 6 SD)
Control Patients
(mean 6 SD)No Retinopathy Retinopathy
Echocardiographic data
LV dimension (cm) 5.0 6 0.6 5.0 6 0.7 4.8 6 0.3
IVS thickness (cm) 1.0 6 0.1 1.0 6 0.2 1.0 6 0.1
Posterior LV wall thickness (cm) 1.0 6 0.2 1.0 6 0.1 1.0 6 0.1
LV mass index (g/m2) 89 6 13 91 6 15 87 6 12
Cardiac catheterization data
Heart rate (beats/min) 71 6 6 73 6 5 70 6 6
Cardiac index (liters/min per m2) 2.8 6 0.6 2.9 6 0.5 2.8 6 0.3
LVEDVI (ml/m2) 72 6 8 73 6 8 69 6 6
LVESVI (ml/m2) 33 6 8 31 6 7 30 6 6
LVEF (%) 60 6 5 63 6 4 61 6 3
Mean aortic pressure (mm Hg) 96 6 6 96 6 11 98 6 8
LVEDP (mm Hg) 8 6 2 10 6 3 9 6 3
PCWP (mm Hg) 7 6 2 8 6 4 8 6 4
Coronary diameter (mm) 2.9 6 0.3* 2.8 6 0.3* 3.1 6 0.4
*p , 0.01 versus control patients. IVS 5 interventricular septum; LV 5 left ventricular; LVEDP 5 left ventricular
end-diastolic pressure; LVEDVI 5 left ventricular end-diastolic volume index; LVEF 5 left ventricular ejection fraction;
LVESVI 5 left ventricular end-systolic volume index; PCWP 5 pulmonary capillary wedge pressure.
Table 1. Clinical Characteristics
Diabetic Patients
Control Patients
(n 5 15)
No Retinopathy
(n 5 11)
Retinopathy
(n 5 18)
Age (yr) 61 6 7 60 6 7 61 6 8
Male/female 7/4 15/3 10/5
Blood glucose (mg/dl) 127 6 21* 139 6 32* 99 6 18
Glycohemoglobin A1c (mg/dl) 6.8 6 1.1* 8.1 6 1.8*
† 5.5 6 1.0
Cholesterol (mg/dl) 193 6 21 202 6 26 201 6 20
Triglycerides (mg/dl) 114 6 28 123 6 24 121 6 44
*p , 0.01 versus control patients. †p , 0.01 versus no retinopathy. Data presented are mean value 6 SD or number
of patients.
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thy, baseline coronary flow was significantly greater in those
with preproliferative than background retinopathy (62 6 16 vs.
52 6 15 ml/min, p , 0.05). Although there was no significant
difference in maximal hyperemic flow velocity among patient
groups, coronary blood flow during maximal hyperemia was
significantly less in patients with and without diabetic retinop-
athy than in control patients and was more marked in those
with preproliferative than background retinopathy (102 6 11
vs 111 6 16, p , 0.05). As a result, coronary flow reserve in
patients with diabetes mellitus was significantly lower than that
in control patients (2.2 6 0.6 vs 3.3 6 0.4, p , 0.01) and was
more pronounced in patients with than without diabetic reti-
nopathy (p , 0.01). Furthermore, restriction of coronary flow
reserve was more prominent in patients with advanced (pre-
proliferative retinopathy) than early diabetic retinopathy
(background retinopathy) (1.6 6 0.2 vs 2.3 6 0.2, p , 0.01).
Discussion
The present study demonstrated that coronary flow reserve
was significantly reduced in patients with diabetes mellitus
compared with that in control patients and was more pro-
nounced in patients with than without diabetic retinopathy.
Furthermore, reduction of coronary flow reserve was more
prominent in patients with the advanced stage of diabetic
retinopathy. These results were due both to the elevation of
basal coronary blood flow and the reduction of maximal
hyperemic coronary blood flow in all diabetic patients. Micro-
vascular dysfunction has been proposed in patients with angina
pectoris, normal coronary arteries and diminished coronary
flow reserve (2,3). Coronary microvascular impairment should
be considered as an explanation for this restricted coronary
flow reserve in patients with diabetes mellitus, and the impair-
Figure 1. Examples of coronary flow velocity
recordings at baseline and during hyperemia in
a control patient (Control) and two patients
with diabetes mellitus (DM), one without (2)
and one with (1) retinopathy. Coronary flow
reserve (FR) is lower in patients with diabetes
mellitus, especially in the patient with diabetic
retinopathy, than in the control patient (1.7 and
2.0 vs. 3.3, respectively) because time-averaged
peak velocities (APV) in the former are far
greater than those in the latter at baseline (48
and 34 vs. 18 cm/s, respectively).
Table 3. Coronary Flow and Flow Velocity Data
Diabetic Patients (mean 6 SD)
Control Patients
(mean 6 SD)No Retinopathy Retinopathy
Coronary flow
Baseline flow (ml/min) 45 6 12* 58 6 16*† 37 6 10
Maximal hyperemic flow (ml/min) 116 6 18* 107 6 23* 136 6 17
Coronary flow reserve 2.8 6 0.3‡ 1.9 6 0.4‡§ 3.3 6 0.4
Coronary flow velocity
Baseline (cm/s) 26 6 4‡ 34 6 10‡§ 18 6 5
Maximal hyperemia (cm/s) 58 6 14 62 6 17 60 6 18
*p , 0.05, ‡p , 0.01 versus control patients. †p , 0.05, §p , 0.01 versus no retinopathy.
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ment of coronary microvessels would be more remarkable in
patients with diabetic retinopathy, especially in those with the
advanced stage of retinopathy.
Maximal coronary flow. Restricted coronary flow reserve
has recently been demonstrated in patients with diabetes
mellitus (4,5). Reduction of the maximal area of the coronary
microcirculation and limited maximal hyperemic flow should
be expected in patients with diabetes mellitus and angiographi-
cally normal epicardial coronary arteries because wall thicken-
ing and lumen narrowing of intramural coronary microvessels
have been described in patients with diabetes mellitus (1). The
present study demonstrated reduced maximal coronary flow
measured in the proximal left anterior descending coronary
artery in patients with diabetes mellitus, which was more
pronounced in patients with diabetic retinopathy, especially in
those with advanced diabetic retinopathy. These results indi-
cate the presence of microvascular impairment in patients with
diabetes mellitus, more so in those with diabetic retinopathy,
especially advanced retinopathy.
Baseline coronary flow. Baseline coronary flow at rest
might be maintained in patients with diabetes mellitus even if
organic lumen narrowing can be found in coronary microves-
sels because compensatory mechanisms would be expected to
maintain basal flow at rest. However, baseline coronary flow in
the present study was significantly greater in patients with
diabetes mellitus than in control patients and was more
pronounced in those with than without diabetic retinopathy.
Calculated coronary flow in the left anterior descending coro-
nary artery in control patients was similar to that in a previous
report using a Doppler guide wire (16) but less than that
measured by the radioisotope method (17) and slightly greater
than that measured by a Doppler catheter (18). These differ-
ences might result from the different methodologies (17,18),
patients studied or measurement position (18), and the flow
volume calculated in the present study should be regarded as
reliable.
Hyperperfusion and increased intravascular pressure have
been proposed as playing a role in the pathogenesis of diabetic
nephropathy (19) and retinopathy (20). Multiple abnormalities
of myocardial metabolism, including altered lactate metabo-
lism, have been demonstrated in diabetic patients without
epicardial coronary artery disease (21), and hyperperfusion
could also be expected at rest in the diabetic heart. Further-
more, elevation of plasma free fatty acid levels has been
demonstrated in patients with diabetes mellitus (22), and it has
been reported that free fatty acids increase myocardial oxygen
consumption (23). Although plasma fatty acid and myocardial
oxygen consumption were not measured in the present study,
higher baseline flow would be expected in patients with
diabetes and might be a characteristic of diabetes mellitus. In
the present study, baseline coronary flow was significantly
greater in patients with diabetes mellitus, being more pro-
nounced in those with than without diabetic retinopathy, and
might be another mechanism of limited flow reserve in patients
with diabetes mellitus, especially in those with diabetic reti-
nopathy. Thus, not only reduced coronary flow during hyper-
emia because of microvascular impairment but also increased
baseline coronary flow from metabolic abnormalities might be
mechanisms of restricted coronary flow reserve in patients with
diabetes mellitus, especially diabetic retinopathy.
Baseline coronary flow velocity was also significantly higher
in diabetic patients, and was also more pronounced in those
with diabetic retinopathy. Elevated coronary flow velocity in
diabetes mellitus may increase longitudinal shear stress at the
endothelial surface (24,25). Mechanical shear stress of endo-
thelial cells has been reported to play an important role in
endothelial permeability (26,27), and increased shear stress
might promote endothelial dysfunction, leading to the devel-
opment of coronary atherosclerosis (28). Elevated basal coro-
nary flow velocity might be related to the progression of
epicardial coronary artery disease in patients with diabetes
mellitus (29,30).
Hyperglycemia and microvascular impairment. Patients
with diabetic mellitus had significantly higher blood glucose
and hemoglobin A1c levels than control patients, and these
levels were also more pronounced in patients with diabetic
retinopathy. Levels of glycemic exposure indicated by glycohe-
moglobin A1c have been reported (31) to be associated with
the risk of long-term complications, including progression of
diabetic retinopathy, and intensive treatment to achieve near-
normal glycemia has been shown to reduce the risk of the
development and progression of microvascular complications.
Thus, long-term glycemic exposure should be regarded as a
cause of retinopathy and coronary microvascular impairment,
and higher blood glucose and hemoglobin A1c levels should be
expected in patients with diabetic retinopathy and restricted
coronary flow reserve.
Individual differences, including coronary perfusion pres-
sure, heart rate and left ventricular preload, although not
significantly different among the three groups in the present
study, might affect coronary flow data (32). Further investiga-
tions should address the results of the present study and the
interactions of the aforementioned factors; nevertheless, re-
duced maximal hyperemic blood flow would appear to indicate
microvascular dysfunction caused by wall thickening and lu-
men narrowing of intramural coronary microvessels in diabetic
patients.
Study limitations. Several limitations of the present study
must be considered. 1) Angiographically normal patients were
included in the present study. Recently developed intravascu-
lar ultrasound has been reported (33) to demonstrate intimal
thickening with a three-layered appearance in the normal
coronary artery in vitro. Localized atherosclerotic lesions have
been confirmed in angiographically minimally diseased coro-
nary arteries by intravascular ultrasound in patients with focal
vasospasm (34). Diffuse concentric thickening of the coronary
vessel wall might be demonstrated by intravascular ultrasound
in patients with diabetes mellitus or diabetic retinopathy
because in the present study, coronary diameters were signif-
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icantly smaller in diabetic patients than in control patients, and
minimally diseased coronary arteries .25% were demon-
strated by angiography in the left circumflex or right coronary
artery in 5 patients. Such differences would be resolved by
intravascular ultrasound. 2) Reduced coronary flow reserve in
angiographically normal coronary arteries has been reported in
patients with hypertension (35) and left ventricular hypertro-
phy (36,37). Therefore, patients with left ventricular hypertro-
phy (35), hypertension, left ventricular dysfunction and valvu-
lar heart disease (37), all of which might reduce coronary flow
reserve, were excluded from the present study. However, it is
possible that patients with borderline hypertension, mild hy-
percholesterolemia or mild microvascular dysfunction might
have been included. Diabetes mellitus has been reported to
diminish coronary flow reserve in patients with hypertension
(38). Hypercholesterolemia (39) and postmenopausal status
(40–42) might have the potential to reduce coronary flow
reserve by impairing endothelium-dependent vasomotion.
Therefore, reduction of coronary flow reserve in patients with
diabetes mellitus is exaggerated in the present study. However,
some of our control patients had mild hypertension or hyper-
cholesterolemia, and some were postmenopausal, and the
effect of these factors on coronary flow reserve would be
similar to that in patients with diabetes. Thus, the reduction of
coronary flow reserve in patients with diabetes, especially those
with diabetic retinopathy, would be similarly demonstrated in
patients without other risk factors that have been reported to
reduce coronary flow reserve. 3) Coronary blood flow was
measured in the proximal left anterior descending coronary
artery. Although it would be preferable to measure and
compare similar variables in the other coronary arteries simul-
taneously, measurements in the left anterior descending coro-
nary artery avoid individual differences in the size and supply-
ing area of the left circumflex and right coronary arteries. 4) As
in all invasive studies, the control subjects in the present study
were undergoing investigation for chest pain. However, nega-
tive exercise test results and normal findings on ECGs, echo-
cardiograms, left ventriculograms and coronary angiograms
were confirmed in all control subjects, and they had no
apparent disorders. Furthermore, they demonstrated normal
coronary flow reserve.
Conclusions. Coronary blood flow is significantly greater at
baseline rest conditions and lower during maximal hyperemia
in patients with diabetes mellitus, and the reduction of maxi-
mal hyperemic coronary flow is more prominent in patients
with than without diabetic retinopathy. As a result, coronary
flow reserve is significantly restricted in patients with diabetes
mellitus and is more pronounced in those with diabetic reti-
nopathy, especially advanced retinopathy. Thus, diabetic reti-
nopathy should be a landmark of marked restriction of coro-
nary flow reserve in patients with diabetes mellitus.
We gratefully acknowledge the assistance of our radiologic technicians in the
recording of coronary flow velocity.
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